CD133 can associate with HDAC6 and β-catenin in a ternary complex that regulates the β-catenin stability, resulting in increased β-catenin co-transcriptional activity in ovarian and CRC cancer cell lines [25]. This evidence concerns the gene PROM1 and colorectal carcinoma.